Kezar Life Sciences Inc is a clinical-stage biotechnology company... Show more
a developer of therapies targeting protein homeostasis
Industry Biotechnology
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Momentum Indicator moved below the 0 level on May 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KZR as a result. In of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .